SlideShare a Scribd company logo
Drugs Affecting Autonomic Nervous
System 1
Lecture objectives
 Identify the anatomy of nervous
system.
 Identify the drugs that effect ANS
lecture_3_drugs_affecting_autonomic_nervous_system_1.ppt
Nervous System Divisions
lecture_3_drugs_affecting_autonomic_nervous_system_1.ppt
Nervous System Overview
 Nervous System
 Brain
 Spinal cord
 Nerves
 Functions of nervous system
 Regulates and coordinates all body
activities
 Center of all mental activity, including
thought, learning, and memory
 Central Nervous System (CNS)
 Brain
 Spinal Cord
 Processes and stores sensory and motor
information
 Controls consciousness
 Peripheral Nervous System (PNS)
 12 Pairs of Cranial Nerves
 31 Pairs of Spinal Nerves
 Transmits sensory and motor impulses back and
forth between CNS and rest of body
Nervous System Divisions
Peripheral Nervous System
 Somatic Nervous System (SNS)
 Provides voluntary control over skeletal
muscle contractions
 Autonomic Nervous System (ANS)
 Provides involuntary control over
smooth muscle, cardiac muscle, and
glandular activity and secretions in
response to the commands of the
central nervous system
 Sympathetic nerves
 Increase heart rate
 Constrict blood vessels
 Raise blood pressure
 Fight-or-flight response
 Parasympathetic nerves
 Slow heart rate
 Increase peristalsis of intestines
 Increase glandular secretions
 Relax sphincters
Autonomic Nervous System
Catecholamines
 Substances that can produce a sympathomimetic
response
1. Endogenous:
Dopamine (Dopaminergic) epinephrine &
norepinephrine (Adrenegeric)
2. Synthetic:
isoproterenol, dobutamine, phenylephrine
Fight or Flight Response:
 These catecholamine hormones facilitate immediate physical
reactions These include the following:
 Acceleration of heart and lung action ・ Inhibition of stomach
and intestinal action
 Constriction of blood vessels in many parts of the body
 Dilation of blood vessels for muscles
 Inhibition of tear glands and salivation
 Dilation of pupil
 Relaxation of bladder
 Inhibition of erection
Dopaminergic Receptors
 An additional adrenergic receptor
 Stimulated by dopamine
 Causes dilation of the following blood
vessels, resulting in INCREASED
blood flow
 Renal
 Mesenteric
 Coronary
 Cerebral
Adrenergic Agents
 Drugs that stimulate the sympathetic
nervous system (SNS)
Also known as:
 adrenergic agonists or sympathomimetics
Mimic the effects of the SNS neurotransmitters:
 norepinephrine (NE) and epinephrine (EPI)
Adrenergic Receptors
 Located throughout the body
 Are receptors for the sympathetic
neurotransmitters
 Alpha-adrenergic receptors:
respond to NE
 Beta-adrenergic receptors: respond
to EPI
Types of -adrenergic receptor
 -adrenergic receptors are adrenergic receptors that respond
to norepinephrine and to such blocking agents as
phenoxybenzamine.
 They are subdivided into two types:
 1, found in smooth muscle, heart, and liver, with effects
including vasoconstriction, intestinal relaxation, uterine
contraction and pupillary dilation,
 2, found in platelets, vascular smooth muscle, nerve termini,
and pancreatic islets, with effects including platelet
aggregation, vasoconstriction, and inhibition of norepinephrine
release and of insulin secretion.
-receptor types
 -adrenergic receptors respond particularly to epinephrine
and to such blocking agents as propranolol.
 There are three known types of beta receptor, designated β1,
β2 and β3.
 β1-Adrenergic receptors are located mainly in the heart.
 β2-Adrenergic receptors are located mainly in the lungs,
gastrointestinal tract, liver, uterus, vascular smooth muscle,
and skeletal muscle.
 β3-receptors are located in fat cells.
What do the receptors do?
Activation of  receptors leads to smooth
muscle contraction
Activation of 2 receptors leads to smooth
muscle relaxation
Activation of 1 receptors leads to smooth
muscle contraction (especially in heart)
Clinical Utility of drugs which affect the adrenergic nervous
system:
a. Agonists of the 2 receptors are used in the
treatment of asthma (relaxation of the smooth muscles of
the bronchi)
b. Antagonists of the 1 receptors are used in
the treatment of hypertension and angina (slow heart and
reduce force of contraction)
c. Antagonists of the 1 receptors are known
to cause lowering of the blood pressure (relaxation of
smooth muscle and dilation of the blood vessels)
Drug Effects of Adrenergic Agents
 Stimulation of alpha-adrenergic receptors on smooth
muscles results in:
 Vasoconstriction of blood vessels
 Relaxation of GI smooth muscles
 Contraction of the uterus and bladder
 Male ejaculation
 Decreased insulin release
 Contraction of the ciliary muscles of the eye
(dilated pupils)
lecture_3_drugs_affecting_autonomic_nervous_system_1.ppt
Drug Effects of Adrenergic Agents
 Stimulation of beta2-adrenergic
receptors on the airways results in:
 Bronchodilation (relaxation of the
bronchi)
 Uterine relaxation
 Glycogenolysis in the liver
lecture_3_drugs_affecting_autonomic_nervous_system_1.ppt
Drug Effects of Adrenergic Agents
 Stimulation of beta1-adrenergic receptors on
the myocardium, AV node, and SA node
results in CARDIAC STIMULATION:
 Increased force of contraction
(positive inotropic effect)
 Increased heart rate
(positive chronotropic effect)
 Increased conduction through the AV node
(positive dromotropic effect) automaticity
Adrenergic Agents:
Therapeutic Uses
1. Anorexiants: adjuncts to diet in the short-term
management of obesity
Examples: benzaphetamine
phentermine
dextroamphetamine
Dexedrine
2.Bronchodilators: treatment of asthma and bronchitis
Agents that stimulate beta2-adrenergic receptors
of bronchial smooth muscles causing relaxation
Examples:
albuterol ephedrine epinephrine
isoetharine isoproterenol levalbuterol
metaproterenol salmeterol terbutaline
Adrenergic Agents: Therapeutic Uses
3. Reduction of intraocular pressure and mydriasis (pupil
dilation): treatment of
open-angle glaucoma
Examples: epinephrine and dipivefrin
4. Nasal decongestant:
Intranasal (topical) application causes constriction
of dilated arterioles and reduction of nasal blood
flow, thus decreasing congestion.
Examples:
epinephrine ephedrine naphazoline phenylephrine
tetrahydrozoline
5. Ophthalmic relieving conjunctival congestion.
Examples: epinephrine naphazoline
phenylephrine tetrahydrozoline
6. Vasoactive sympathomimetics also called cardio selective
sympathomimetics
Used to support the heart during cardiac failure or shock.
Examples:
dobutamine dopamine ephedrine epinephrine
fenoldopam isoproterenol methoxamine
norepinephrine phenylephrine
Adrenergic Agents: Side Effects
 Alpha-Adrenergic Effects
 CNS:
 headache, restlessness, excitement, insomnia,
euphoria
 Cardiovascular:
 palpitations (dysrhythmias), tachycardia,
vasoconstriction, hypertension
 Other:
 anorexia, dry mouth, nausea, vomiting, taste
changes (rare)
Adrenergic Agents: Side Effects
 Beta-Adrenergic Effects
 CNS:
 mild tremors, headache, nervousness,
dizziness
 Cardiovascular:
 increased heart rate, palpitations
(dysrhythmias), fluctuations in BP
 Other:
 sweating, nausea, vomiting, muscle
cramps
Adrenergic Agents:
Nursing Implications
 Assess for allergies and history of
hypertension, cardiac dysrhythmias, or other
cardiovascular disease.
 Assess renal, hepatic, and cardiac function
before treatment.
 Perform baseline assessment of vital signs,
peripheral pulses, skin color, temperature,
and capillary refill. Include postural blood
pressure and pulse.
 Follow administration guidelines carefully.
Adrenergic Agents: Nursing Implications
With chronic lung disease:
Instruct patients to avoid factors that
exacerbate their condition.
Encourage fluid intake
(up to 3000 mL per day) if permitted.
Educate about proper dosing and
equipment care.
Adrenergic Agents: Nursing Implications
 Overuse of nasal decongestants may cause
rebound nasal congestion or ulcerations.
 Monitor for therapeutic effects
(cardiovascular uses):
 Decreased edema
 Increased urinary output
 Return to normal vital signs
 Improved skin color and temperature
 Increased LOC
Adrenergic Agents: Nursing Implications
 Monitor for therapeutic effects (asthma):
 Return to normal respiratory rate
 Improved breath sounds, fewer rales
 Increased air exchange
 Decreased cough
 Less dyspnea
 Improved blood gases
 Increased activity tolerance
Adrenergic-Blocking Agents
 Bind to adrenergic receptors, but inhibit or block
stimulation of the sympathetic nervous system (SNS)
 Have the opposite effect of adrenergic agents
 Also known as
 adrenergic antagonists or sympatholytics
Adrenergic-Blocking Agents:
Drug Effects and Therapeutic Uses
 Alpha-Blockers
 Cause both arterial and venous dilation,
reducing peripheral vascular resistance and
BP
 Used to treat hypertension
 Effect on receptors on prostate gland and
bladder decreased resistance to urinary
outflow, thus reducing urinary obstruction
and relieving effects
of BPH
Beta Blockers: Mechanism of
Action
 Cardioselective (Beta1)
 Decreases heart rate
 Prolongs SA node recovery
 Slows conduction rate through the
AV node
 Decreases myocardial contractility,
thus decreasing myocardial oxygen
demand
Beta Blockers: Therapeutic
Uses
1. Anti-angina:decreases demand for myocardial
oxygen
2. Cardioprotective:inhibits stimulation by
circulating catecholamines
3. Class II antidysrhythmic
4. Antihypertensive
5. Treatment of migraine headaches
6. Glaucoma (topical use)
Adrenergic Blocking Agents:
Nursing Implications
 Assess for allergies and history of COPD,
hypotension, cardiac dysrhythmias,
bradycardia, CHF, or other cardiovascular
problems
 Remember that alpha blockers may
precipitate hypotension.
 Remember that beta blockers may
precipitate bradycardia, hypotension,
heart block, CHF, and bronchoconstriction.
 Encourage patients to take medications
as prescribed.
 These medications should never be stopped abruptly.
 Report constipation or the development of any urinary or
bladder distention.
 Rebound hypertension or chest pain may occur if this
medication is discontinued abruptly.
 Patients should notify their physician if they become ill and
unable to take medication.
 Inform patients that they may notice a decrease in their
tolerance for exercise; dizziness and fainting may occur with
increased activity. Notify the physician if these problems
occur.
Beta Blocking Agents:
Nursing Implications
 Patients should report the following to
their physician:
1. Weight gain of more than 2 pounds (1 kg)
within a week
2. Edema of the feet or ankles
3. Shortness of breath
4. Excessive fatigue or weakness
5. Syncope or dizziness
Monitor for side effects, including:
1. Hypotension
2. Fatigue
3. Tachycardia (alpha blockers)
4. Lethargy
5. Bradycardia
6. Depression
7. Heart block
8. Insomnia
9. CHF
10.nightmares
11.Increased airway resistance
QUESTION?

More Related Content

PPT
Adrenergic blockers
PPT
NurseReview.Org - Adrenergic Blockers
PPT
03 Adrenergic Blockers Upd
PPTX
PRESENTATION FOR Sympathomimetic drugs2 [Autosaved].pptx
PPT
AUTONOMIC_SYSTEM.O__14b92314562u8824d.ppt
PPT
AUTONOMIC_SYSTEM.O__14b9234d.ppt
PPT
AUTONOMIC_SYSTEM.O__14b9234d.ppt
PPT
Adrenergic_and_anti-adrenergic_drugs.ppt
Adrenergic blockers
NurseReview.Org - Adrenergic Blockers
03 Adrenergic Blockers Upd
PRESENTATION FOR Sympathomimetic drugs2 [Autosaved].pptx
AUTONOMIC_SYSTEM.O__14b92314562u8824d.ppt
AUTONOMIC_SYSTEM.O__14b9234d.ppt
AUTONOMIC_SYSTEM.O__14b9234d.ppt
Adrenergic_and_anti-adrenergic_drugs.ppt

Similar to lecture_3_drugs_affecting_autonomic_nervous_system_1.ppt (20)

PPT
Adrenergic and anti-adrenergic drugs.ppt
PPT
Adrenergic_and_anti-adrenergic_drugs.ppt
PPT
Adrenergic_and_anti-adrenergic_drugs.ppt
PDF
Adrenergic drugs - pharmacology
PPSX
Effects of sympathomimetic drugs on the cardiovascular system
PDF
Drugs acting on ANS By MIW sir ,department of pharmacy,university of rajshahi...
PPTX
Inotropes and Vasopressors.pptx
PDF
ANS Pharmacology- Adrenergic Drugs
DOCX
Pharm tutorial questions
PPTX
Ch 18 autonomic nervous system agents pharm
PPTX
Drugs-Affecting-ANS.pptx Drugs-Affecting-ANS.pptx Drugs-Affecting-ANS.pptx Dr...
PPTX
1. Anti hypertensive drugs.pptx what's hypertension
PPTX
Sympathomimetic Amines.presentation, rahul gholse
PPT
Pharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. Pawan
PPT
Autonomic Nervous System Agents
PPTX
drugs that affect the autonomic nervous system.ppt [autosaved] [autosaved]
PPT
lesson3yvffjngffhjbffuknvdsdgghvssddffgvhh
PPT
NurseReview.Org - Cholinergic Blockers Updates (pharmacology summaries)
PPT
04 Cholinergic Blockers Upd
PPTX
Uppers downers and squeezers
Adrenergic and anti-adrenergic drugs.ppt
Adrenergic_and_anti-adrenergic_drugs.ppt
Adrenergic_and_anti-adrenergic_drugs.ppt
Adrenergic drugs - pharmacology
Effects of sympathomimetic drugs on the cardiovascular system
Drugs acting on ANS By MIW sir ,department of pharmacy,university of rajshahi...
Inotropes and Vasopressors.pptx
ANS Pharmacology- Adrenergic Drugs
Pharm tutorial questions
Ch 18 autonomic nervous system agents pharm
Drugs-Affecting-ANS.pptx Drugs-Affecting-ANS.pptx Drugs-Affecting-ANS.pptx Dr...
1. Anti hypertensive drugs.pptx what's hypertension
Sympathomimetic Amines.presentation, rahul gholse
Pharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. Pawan
Autonomic Nervous System Agents
drugs that affect the autonomic nervous system.ppt [autosaved] [autosaved]
lesson3yvffjngffhjbffuknvdsdgghvssddffgvhh
NurseReview.Org - Cholinergic Blockers Updates (pharmacology summaries)
04 Cholinergic Blockers Upd
Uppers downers and squeezers
Ad

More from mousaderhem1 (20)

PPT
chapter13333333333333333333333333333333.ppt
PPTX
Thursday-II-ffffffffffffffffffffffffffffffffffffffffffC.pptx
PPTX
AGREE-Summary-Datffffffffffffffffffffffffa.pptx
PPT
_AJ_spinal_cord2222222222222222222_2.ppt
PPT
AIGeneralSession1DrCarrollyyyyyyyyyyyyyy.ppt
PPT
2022 Roles and responsibilites of Nursing Organizations.ppt
PPT
NRS101Session2LegalIssuesinNursingPracticeWI.ppt
PPTX
Sample Presentationyyyyyyyyyyyyyyyyyyyyy.pptx
PPTX
unit-iiinonparametrictestsbsrm-221019091259-e57b4925.pptx
PPT
reliability-and-validity-in-psychological-research.ppt
PPT
4 - Thomas Ozorowskihhhhhhhhhhhhhhhh.ppt
PPT
carcinoma_cervix2222222222222222222222222222222.ppt
PPT
L02_--_Basic_Research_and_Experimental_Methods(1).ppt
PPT
Ethics Primekkkkkkkkkkkkkkkkkkkkr 4-17.ppt
PPT
62071-Cultural-Competence-for-Clinicians-Session-A.ppt
PPTX
psmgffgggggggggggggggggggggggggggggggg.pptx
PPTX
6c_llerasmuneyddddddddddddddddddddd.pptx
PPT
discussion4(2)jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjj.ppt
PPT
Behavioural-theories-powerpoikkkkkkkkkkkknt.ppt
PPT
Operant_Conditioning_Slide(oooooooooooooo1).ppt
chapter13333333333333333333333333333333.ppt
Thursday-II-ffffffffffffffffffffffffffffffffffffffffffC.pptx
AGREE-Summary-Datffffffffffffffffffffffffa.pptx
_AJ_spinal_cord2222222222222222222_2.ppt
AIGeneralSession1DrCarrollyyyyyyyyyyyyyy.ppt
2022 Roles and responsibilites of Nursing Organizations.ppt
NRS101Session2LegalIssuesinNursingPracticeWI.ppt
Sample Presentationyyyyyyyyyyyyyyyyyyyyy.pptx
unit-iiinonparametrictestsbsrm-221019091259-e57b4925.pptx
reliability-and-validity-in-psychological-research.ppt
4 - Thomas Ozorowskihhhhhhhhhhhhhhhh.ppt
carcinoma_cervix2222222222222222222222222222222.ppt
L02_--_Basic_Research_and_Experimental_Methods(1).ppt
Ethics Primekkkkkkkkkkkkkkkkkkkkr 4-17.ppt
62071-Cultural-Competence-for-Clinicians-Session-A.ppt
psmgffgggggggggggggggggggggggggggggggg.pptx
6c_llerasmuneyddddddddddddddddddddd.pptx
discussion4(2)jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjj.ppt
Behavioural-theories-powerpoikkkkkkkkkkkknt.ppt
Operant_Conditioning_Slide(oooooooooooooo1).ppt
Ad

Recently uploaded (20)

PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PPTX
Acid Base Disorders educational power point.pptx
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
vertigo topics for undergraduate ,mbbs/md/fcps
PPTX
Neuropathic pain.ppt treatment managment
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPTX
preoerative assessment in anesthesia and critical care medicine
PPTX
Anatomy and physiology of the digestive system
PPTX
Spontaneous Subarachinoid Haemorrhage. Ppt
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPTX
regulatory aspects for Bulk manufacturing
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PPTX
2 neonat neotnatology dr hussein neonatologist
PPTX
Clinical approach and Radiotherapy principles.pptx
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PDF
Human Health And Disease hggyutgghg .pdf
PPTX
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
CHEM421 - Biochemistry (Chapter 1 - Introduction)
Acid Base Disorders educational power point.pptx
Copy of OB - Exam #2 Study Guide. pdf
vertigo topics for undergraduate ,mbbs/md/fcps
Neuropathic pain.ppt treatment managment
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
preoerative assessment in anesthesia and critical care medicine
Anatomy and physiology of the digestive system
Spontaneous Subarachinoid Haemorrhage. Ppt
Obstructive sleep apnea in orthodontics treatment
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
regulatory aspects for Bulk manufacturing
focused on the development and application of glycoHILIC, pepHILIC, and comm...
2 neonat neotnatology dr hussein neonatologist
Clinical approach and Radiotherapy principles.pptx
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
Human Health And Disease hggyutgghg .pdf
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...

lecture_3_drugs_affecting_autonomic_nervous_system_1.ppt

  • 1. Drugs Affecting Autonomic Nervous System 1
  • 2. Lecture objectives  Identify the anatomy of nervous system.  Identify the drugs that effect ANS
  • 6. Nervous System Overview  Nervous System  Brain  Spinal cord  Nerves  Functions of nervous system  Regulates and coordinates all body activities  Center of all mental activity, including thought, learning, and memory
  • 7.  Central Nervous System (CNS)  Brain  Spinal Cord  Processes and stores sensory and motor information  Controls consciousness  Peripheral Nervous System (PNS)  12 Pairs of Cranial Nerves  31 Pairs of Spinal Nerves  Transmits sensory and motor impulses back and forth between CNS and rest of body Nervous System Divisions
  • 8. Peripheral Nervous System  Somatic Nervous System (SNS)  Provides voluntary control over skeletal muscle contractions  Autonomic Nervous System (ANS)  Provides involuntary control over smooth muscle, cardiac muscle, and glandular activity and secretions in response to the commands of the central nervous system
  • 9.  Sympathetic nerves  Increase heart rate  Constrict blood vessels  Raise blood pressure  Fight-or-flight response  Parasympathetic nerves  Slow heart rate  Increase peristalsis of intestines  Increase glandular secretions  Relax sphincters Autonomic Nervous System
  • 10. Catecholamines  Substances that can produce a sympathomimetic response 1. Endogenous: Dopamine (Dopaminergic) epinephrine & norepinephrine (Adrenegeric) 2. Synthetic: isoproterenol, dobutamine, phenylephrine
  • 11. Fight or Flight Response:  These catecholamine hormones facilitate immediate physical reactions These include the following:  Acceleration of heart and lung action ・ Inhibition of stomach and intestinal action  Constriction of blood vessels in many parts of the body  Dilation of blood vessels for muscles  Inhibition of tear glands and salivation  Dilation of pupil  Relaxation of bladder  Inhibition of erection
  • 12. Dopaminergic Receptors  An additional adrenergic receptor  Stimulated by dopamine  Causes dilation of the following blood vessels, resulting in INCREASED blood flow  Renal  Mesenteric  Coronary  Cerebral
  • 13. Adrenergic Agents  Drugs that stimulate the sympathetic nervous system (SNS) Also known as:  adrenergic agonists or sympathomimetics Mimic the effects of the SNS neurotransmitters:  norepinephrine (NE) and epinephrine (EPI)
  • 14. Adrenergic Receptors  Located throughout the body  Are receptors for the sympathetic neurotransmitters  Alpha-adrenergic receptors: respond to NE  Beta-adrenergic receptors: respond to EPI
  • 15. Types of -adrenergic receptor  -adrenergic receptors are adrenergic receptors that respond to norepinephrine and to such blocking agents as phenoxybenzamine.  They are subdivided into two types:  1, found in smooth muscle, heart, and liver, with effects including vasoconstriction, intestinal relaxation, uterine contraction and pupillary dilation,  2, found in platelets, vascular smooth muscle, nerve termini, and pancreatic islets, with effects including platelet aggregation, vasoconstriction, and inhibition of norepinephrine release and of insulin secretion.
  • 16. -receptor types  -adrenergic receptors respond particularly to epinephrine and to such blocking agents as propranolol.  There are three known types of beta receptor, designated β1, β2 and β3.  β1-Adrenergic receptors are located mainly in the heart.  β2-Adrenergic receptors are located mainly in the lungs, gastrointestinal tract, liver, uterus, vascular smooth muscle, and skeletal muscle.  β3-receptors are located in fat cells.
  • 17. What do the receptors do? Activation of  receptors leads to smooth muscle contraction Activation of 2 receptors leads to smooth muscle relaxation Activation of 1 receptors leads to smooth muscle contraction (especially in heart)
  • 18. Clinical Utility of drugs which affect the adrenergic nervous system: a. Agonists of the 2 receptors are used in the treatment of asthma (relaxation of the smooth muscles of the bronchi) b. Antagonists of the 1 receptors are used in the treatment of hypertension and angina (slow heart and reduce force of contraction) c. Antagonists of the 1 receptors are known to cause lowering of the blood pressure (relaxation of smooth muscle and dilation of the blood vessels)
  • 19. Drug Effects of Adrenergic Agents  Stimulation of alpha-adrenergic receptors on smooth muscles results in:  Vasoconstriction of blood vessels  Relaxation of GI smooth muscles  Contraction of the uterus and bladder  Male ejaculation  Decreased insulin release  Contraction of the ciliary muscles of the eye (dilated pupils)
  • 21. Drug Effects of Adrenergic Agents  Stimulation of beta2-adrenergic receptors on the airways results in:  Bronchodilation (relaxation of the bronchi)  Uterine relaxation  Glycogenolysis in the liver
  • 23. Drug Effects of Adrenergic Agents  Stimulation of beta1-adrenergic receptors on the myocardium, AV node, and SA node results in CARDIAC STIMULATION:  Increased force of contraction (positive inotropic effect)  Increased heart rate (positive chronotropic effect)  Increased conduction through the AV node (positive dromotropic effect) automaticity
  • 24. Adrenergic Agents: Therapeutic Uses 1. Anorexiants: adjuncts to diet in the short-term management of obesity Examples: benzaphetamine phentermine dextroamphetamine Dexedrine 2.Bronchodilators: treatment of asthma and bronchitis Agents that stimulate beta2-adrenergic receptors of bronchial smooth muscles causing relaxation Examples: albuterol ephedrine epinephrine isoetharine isoproterenol levalbuterol metaproterenol salmeterol terbutaline
  • 25. Adrenergic Agents: Therapeutic Uses 3. Reduction of intraocular pressure and mydriasis (pupil dilation): treatment of open-angle glaucoma Examples: epinephrine and dipivefrin 4. Nasal decongestant: Intranasal (topical) application causes constriction of dilated arterioles and reduction of nasal blood flow, thus decreasing congestion. Examples: epinephrine ephedrine naphazoline phenylephrine tetrahydrozoline
  • 26. 5. Ophthalmic relieving conjunctival congestion. Examples: epinephrine naphazoline phenylephrine tetrahydrozoline 6. Vasoactive sympathomimetics also called cardio selective sympathomimetics Used to support the heart during cardiac failure or shock. Examples: dobutamine dopamine ephedrine epinephrine fenoldopam isoproterenol methoxamine norepinephrine phenylephrine
  • 27. Adrenergic Agents: Side Effects  Alpha-Adrenergic Effects  CNS:  headache, restlessness, excitement, insomnia, euphoria  Cardiovascular:  palpitations (dysrhythmias), tachycardia, vasoconstriction, hypertension  Other:  anorexia, dry mouth, nausea, vomiting, taste changes (rare)
  • 28. Adrenergic Agents: Side Effects  Beta-Adrenergic Effects  CNS:  mild tremors, headache, nervousness, dizziness  Cardiovascular:  increased heart rate, palpitations (dysrhythmias), fluctuations in BP  Other:  sweating, nausea, vomiting, muscle cramps
  • 29. Adrenergic Agents: Nursing Implications  Assess for allergies and history of hypertension, cardiac dysrhythmias, or other cardiovascular disease.  Assess renal, hepatic, and cardiac function before treatment.  Perform baseline assessment of vital signs, peripheral pulses, skin color, temperature, and capillary refill. Include postural blood pressure and pulse.  Follow administration guidelines carefully.
  • 30. Adrenergic Agents: Nursing Implications With chronic lung disease: Instruct patients to avoid factors that exacerbate their condition. Encourage fluid intake (up to 3000 mL per day) if permitted. Educate about proper dosing and equipment care.
  • 31. Adrenergic Agents: Nursing Implications  Overuse of nasal decongestants may cause rebound nasal congestion or ulcerations.  Monitor for therapeutic effects (cardiovascular uses):  Decreased edema  Increased urinary output  Return to normal vital signs  Improved skin color and temperature  Increased LOC
  • 32. Adrenergic Agents: Nursing Implications  Monitor for therapeutic effects (asthma):  Return to normal respiratory rate  Improved breath sounds, fewer rales  Increased air exchange  Decreased cough  Less dyspnea  Improved blood gases  Increased activity tolerance
  • 33. Adrenergic-Blocking Agents  Bind to adrenergic receptors, but inhibit or block stimulation of the sympathetic nervous system (SNS)  Have the opposite effect of adrenergic agents  Also known as  adrenergic antagonists or sympatholytics
  • 34. Adrenergic-Blocking Agents: Drug Effects and Therapeutic Uses  Alpha-Blockers  Cause both arterial and venous dilation, reducing peripheral vascular resistance and BP  Used to treat hypertension  Effect on receptors on prostate gland and bladder decreased resistance to urinary outflow, thus reducing urinary obstruction and relieving effects of BPH
  • 35. Beta Blockers: Mechanism of Action  Cardioselective (Beta1)  Decreases heart rate  Prolongs SA node recovery  Slows conduction rate through the AV node  Decreases myocardial contractility, thus decreasing myocardial oxygen demand
  • 36. Beta Blockers: Therapeutic Uses 1. Anti-angina:decreases demand for myocardial oxygen 2. Cardioprotective:inhibits stimulation by circulating catecholamines 3. Class II antidysrhythmic 4. Antihypertensive 5. Treatment of migraine headaches 6. Glaucoma (topical use)
  • 37. Adrenergic Blocking Agents: Nursing Implications  Assess for allergies and history of COPD, hypotension, cardiac dysrhythmias, bradycardia, CHF, or other cardiovascular problems  Remember that alpha blockers may precipitate hypotension.  Remember that beta blockers may precipitate bradycardia, hypotension, heart block, CHF, and bronchoconstriction.
  • 38.  Encourage patients to take medications as prescribed.  These medications should never be stopped abruptly.  Report constipation or the development of any urinary or bladder distention.  Rebound hypertension or chest pain may occur if this medication is discontinued abruptly.  Patients should notify their physician if they become ill and unable to take medication.  Inform patients that they may notice a decrease in their tolerance for exercise; dizziness and fainting may occur with increased activity. Notify the physician if these problems occur.
  • 39. Beta Blocking Agents: Nursing Implications  Patients should report the following to their physician: 1. Weight gain of more than 2 pounds (1 kg) within a week 2. Edema of the feet or ankles 3. Shortness of breath 4. Excessive fatigue or weakness 5. Syncope or dizziness
  • 40. Monitor for side effects, including: 1. Hypotension 2. Fatigue 3. Tachycardia (alpha blockers) 4. Lethargy 5. Bradycardia 6. Depression 7. Heart block 8. Insomnia 9. CHF 10.nightmares 11.Increased airway resistance